Skip to main content
Caplight Logo









SiVEC Biotechnologies

SiVEC Biotechnologies

Private
Fort Collins, ColoradoHealthcare & Life Scienceshttps://www.sivecbiotechnologies.com/

Last Round

Seed

Oct 9, 2025

Total Funding Raised

$1.81M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

SiVEC Biotechnologies is a biotechnology company that develops a live biotherapeutic delivery platform called BactPac for the targeted delivery of nucleic acid and gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

live biotherapeuticdrug delivery platformgene editingnucleic acid deliveryCRISPR deliverybacterial deliverybiotech partneringmRNA deliverysiRNA therapybiopharma licensingtargeted therapysynthetic biologydrug delivery techbio-deliverynon-viral delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SiVEC Biotechnologies Comparables

Compare SiVEC Biotechnologies with similar companies based on industry and business-model similarity.

SiVEC Biotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GenCirq, Inc.
82%
Neobe Therapeutics
80%
NanoSyrinx
78%

SiVEC Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedOct 9, 2025
GrantNov 1, 2024
GrantMay 18, 2023
GrantSep 1, 2022
GrantMay 21, 2020
Grant
Sep 1, 2019

SiVEC Biotechnologies Investors

Notable investors and investment history

SiVEC Biotechnologies investors
InvestorRounds
National Institute of Allergy and Infectious DiseasesGrant
Silicon Valley BankGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 180% MoM.

  • Jun 19, 2026

    Monthly visitors increased 33% MoM, reaching 501.

SiVEC Biotechnologies Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SiVEC Biotechnologies Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SiVEC Biotechnologies's valuation, stock price, and market status.

Firmographic Details

HeadquartersFort Collins, Colorado
Employee Range3
Year Founded2016
Last FundingOct 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?